Aster Capital Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Aster Capital Management's MRNA Position: Q3 2026 in Review
Aster Capital Management opened a new position in Moderna (MRNA) in Q3 2026: 6,700 shares worth $1.29M. The stake represents 0.47% of the portfolio and ranks #35 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in MRNA as recently as Q4 2024.
Aster Capital Management first reported a position in MRNA in Q4 2024 and has held it in 2 quarters since. 1,032 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- Aster Capital Management held 6,700 shares of Moderna worth $1.29M as of Q3 2026.
- Moderna was a new Aster Capital Management position in Q3 2026.
- Moderna made up 0.47% of Aster Capital Management's portfolio in Q3 2026, its #35 holding.
- Aster Capital Management first reported a position in Moderna in Q4 2024 and has held it in 2 quarters since.
- 1,032 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.